We are live on ! Find out more
VanEck Associates

VanEck Associates Portfolio holdings

AUM $133B
1-Year Est. Return 72.99%
This Fund
S&P 500
This Quarter Est. Return
+6.67%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$133B
AUM Growth
+$12.2B
Cap. Flow
+$7.34B
Cap. Flow %
5.51%
Top 10 Hldgs %
31.59%
Holding
1,470
New
67
Increased
946
Reduced
372
Closed
66

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.09B
2
AEM icon
Agnico Eagle Mines
AEM
+$830M
3
AVGO icon
Broadcom
AVGO
+$763M
4
NEM icon
Newmont
NEM
+$717M
5
TSM icon
TSMC
TSM
+$618M

Sector Composition

Rank Sector Weight
1 Technology 41.47%
2 Materials 28.65%
3 Industrials 6.66%
4 Energy 5.06%
5 Healthcare 4.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KSPI icon
726
Kaspi.kz JSC
KSPI
$16.2B
$6.53M ﹤0.01%
88,091
-317
-0.4% -$23.9K
CPT icon
727
Camden Property Trust
CPT
$11.2B
$6.51M ﹤0.01%
66,705
+6,973
+12% +$739K
JPM icon
728
JPMorgan Chase
JPM
$923B
$6.48M ﹤0.01%
22,019
-720
-3% -$219K
EPAM icon
729
EPAM Systems
EPAM
$4.45B
$6.47M ﹤0.01%
47,826
-13,832
-22% -$2.36M
CI icon
730
Cigna
CI
$75.7B
$6.47M ﹤0.01%
24,271
-6,182
-20% -$1.71M
CAH icon
731
Cardinal Health
CAH
$52.3B
$6.44M ﹤0.01%
30,492
-1,541
-5% -$332K
IBP icon
732
Installed Building Products
IBP
$5.91B
$6.44M ﹤0.01%
24,285
-129
-0.5% -$38.6K
CORT icon
733
Corcept Therapeutics
CORT
$10.4B
$6.43M ﹤0.01%
159,550
-1,414
-0.9% -$52.9K
FMC icon
734
FMC
FMC
$1.44B
$6.39M ﹤0.01%
371,356
+160,746
+76% +$2.4M
MPLX icon
735
MPLX
MPLX
$58.2B
$6.39M ﹤0.01%
112,001
+45,762
+69% +$2.59M
HDB icon
736
HDFC Bank
HDB
$118B
$6.39M ﹤0.01%
256,847
-4,962
-2% -$154K
AXSM icon
737
Axsome Therapeutics
AXSM
$12.4B
$6.37M ﹤0.01%
37,673
+2,596
+7% +$448K
CRL icon
738
Charles River Laboratories
CRL
$10.9B
$6.35M ﹤0.01%
36,826
+1,325
+4% +$246K
EMA
739
Emera Inc
EMA
$16.7B
$6.34M ﹤0.01%
122,383
+6,670
+6% +$338K
MS icon
740
Morgan Stanley
MS
$337B
$6.33M ﹤0.01%
38,457
-4,377
-10% -$758K
POOL icon
741
Pool Corp
POOL
$6.9B
$6.33M ﹤0.01%
31,282
+1,151
+4% +$271K
NFG icon
742
National Fuel Gas
NFG
$7.85B
$6.29M ﹤0.01%
66,892
+2,404
+4% +$210K
PPC icon
743
Pilgrim's Pride
PPC
$6.58B
$6.25M ﹤0.01%
165,532
+74,184
+81% +$2.99M
EGP icon
744
EastGroup Properties
EGP
$11.6B
$6.2M ﹤0.01%
33,497
+4,188
+14% +$782K
HIMS icon
745
Hims & Hers Health
HIMS
$7.73B
$6.17M ﹤0.01%
297,024
+65,851
+28% +$1.56M
SSD icon
746
Simpson Manufacturing
SSD
$7.7B
$6.16M ﹤0.01%
35,901
+1,294
+4% +$239K
BLDP
747
Ballard Power Systems
BLDP
$916M
$6.15M ﹤0.01%
2,541,740
+271,407
+12% +$647K
RWT
748
Redwood Trust
RWT
$611M
$6.15M ﹤0.01%
1,096,248
-6,430
-0.6% -$37.3K
CRWD icon
749
CrowdStrike
CRWD
$186B
$6.13M ﹤0.01%
62,768
+7,672
+14% +$813K
JD icon
750
JD.com
JD
$40.6B
$6.11M ﹤0.01%
206,561
+4,750
+2% +$134K

Similar funds

VanEck Associates's Q1 2026 Portfolio in Review

As of Q1 2026, VanEck Associates held 1,470 positions worth $133B, up 10% from $121B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

VanEck Associates deployed $7.34B of net new capital in Q1 2026, opening 67 new positions and adding to 946 existing holdings. Its largest new stake was United States Antimony: 10,369,695 shares worth $90.5M.

By sector, the portfolio is most concentrated in Technology at 41% of assets, down from 42% a quarter earlier, followed by Materials and Industrials.

On the sell side, the largest reduction was Pan American Silver, an estimated $1.04B trimmed.

  • VanEck Associates's largest Q1 2026 buy was United States Antimony: 10,369,695 shares worth $90.5M.
  • VanEck Associates added most to NVIDIA in Q1 2026, an estimated $1.09B increase.
  • VanEck Associates's biggest Q1 2026 reduction was Pan American Silver, cutting an estimated $1.04B.
  • VanEck Associates fully exited Ur-Energy in Q1 2026, selling an estimated $28.4M.
  • VanEck Associates's ten largest holdings make up 32% of its $133B portfolio in Q1 2026.
  • VanEck Associates opened 67 new positions and closed 66 in Q1 2026.
  • VanEck Associates's portfolio value rose 10% quarter-over-quarter to $133B.

Based on VanEck Associates's 13F filing for Q1 2026, filed 15 May 2026.